FDA Adverse Event Injury Summary report: N

TUMARK VISION FOR EVIVA STANDARD

MDR report key: 25057175 · Received May 1, 2026

Report

Report Number
3030927217-2026-00002
Event Type
Injury
Date Received
May 1, 2026
Date of Event
September 16, 2025
Report Date
May 1, 2026
Manufacturer
SOMATEX MEDICAL TECHNOLOGIES GMBH
Product Code
NEU
UDI-DI
04250195611222
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

DEVICE HISTORY RECORD (DHR) REVIEW WAS UNABLE TO BE CONDUCTED FOR THE DEVICE AT THE TIME OF THIS REPORT. THE DEVICE INVOLVED IN THIS EVENT WAS NOT RETURNED FOR EVALUATION PURPOSES THEREFORE VISUAL AND FUNCTIONAL ANALYSIS OF THE PRODUCT COULD NOT BE PERFORMED. WE ARE UNABLE TO CONFIRM A RELATIONSHIP BETWEEN THE DEVICE AND THE ISSUE REPORTED.

Description of Event or Problem · 0

HOLOGIC HAS RECEIVED CORRESPONDENCE ARISING FROM LITIGATION. THE LITIGATION ALLEGES THAT A PATIENT RECEIVED A TUMARK VISION FOR EVIVA STANDARD BREAST MARKER ON (B)(6) 2021. IT IS FURTHER ALLEGED THAT THE PATIENT DEVELOPED A "SEVERE INFLAMMATORY REACTION," AND THE DEVICE WAS SURGICALLY REMOVED ON (B)(6) 2025. ADDITIONALLY, IT IS REPORTED THAT DIAGNOSIS OF THE EXCISED TISSUE CONFIRMED THE PRESENCE OF "FOREIGN BODY GRANULOMA."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
63265 TUMARK VISION FOR EVIVA STANDARD MARKER, RADIOGRAPHIC, IMPLANTABLE NEU SOMATEX MEDICAL TECHNOLOGIES GMBH TUMARK-E13-S-VISION 190509009 04250195611222

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other